Home »

AtCor Medical Receives FDA Clearance for SphygmoCor(R) XCEL

New Cuff-Based System Measures Brachial and Central Aortic Blood Pressures

AtCor Medical Announces $3.2 Million Pharmaceutical Clinical Trial Contract

ITASCA, IL — (Marketwire) — 10/08/12 — AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor® system, which measures central aortic pressures and arterial stiffness noninvasively, today announced that it has signed a contract to supply SphygmoCor® systems and clinical trial support services to a major pharmaceutical company. Systems will be placed at sites throughout Europe and North America. The value of the contract is approximately $3.2 million.Duncan Ross, CEO of

New Study Finds That Arterial Stiffness Precedes Hypertension

Targeting and Treating Arterial Stiffness May Help Prevent Hypertension

Analytics

© 2020 88Finance. All Rights Reserved. Log in - Copyright by LayerMedia


Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de